EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57

Abstract

A CLINICAL STUDY ON HARIDRA (CURCUMA LONGA LINN.), DARUHARIDRA (BERBERIS ARISTATA DC.) AND AMALAKI (EMBLICA OFFICINALIS GAERTN.) IN MADHUMEHA (DM TYPE 2)

Sarvesh Kumar Bharati*, Bhuwal Ram, Surya Kumar Singh and Anil Kumar Singh

ABSTRACT

Ayurveda was practiced and preached for the betterment of human beings. Its primary aim was attainment of sustainable health while patients were treated by using natural products. The present clinical study was done with an aim to evaluate the Effect of Haridra (Curcuma longa Linn.) and Daruharidra (Berberis aristata DC.) processed with Amalaki (Emblica officinalis Gaertn.) swarasa in Madhumeha (DM Type 2). According to Ayurveda, Madhumeha is defined as the disease in which patient voids urine similar to Madhu (honey) in taste and colour. Diabetes mellitus is a syndrome, characterized by hyperglycemia resulting from defects in insulin secretion, insulin resistance or both. In India, the prevalence of Type 2 DM between age group 20-79 years is 91.3 million in year 2011 and expected data in 2030 is 101.2 million according to International Diabetes Federation. Present study consists of 60 registered cases of Type 2 DM which is divided in 3 groups i.e. Group A, B and C having 20 cases in each. Out of these, 10 cases did not follow the treatment thus the present study population includes only 50 patients. Group A was treated with trial drug, group B was treated with tablet Gliclazide and group C was treated with both the trial drug and Gliclazide. In group C, significant statistical and clinical changes were observed in reduction of Fasting Blood Sugar followed by group „A‟ and „B‟. Effect on Post Prandial Blood Sugar was highly significant in group „A‟ followed by group „C‟ and „B‟. There was statistically significant reduction in HbA1c in group C. Lastly it is concluded that this trial drug is an effective therapeutic medicine for management of Madhumeha (Type 2 D.M).

Keywords: Haridra, Daruharidra, Amalaki, Madhumeha, Ayurveda, Diabetes.


[Full Text Article]

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 December 2021 Issue has been Published, Kindly check it on http://www.ejpmr.com/home/current_issues

  • EJPMR: DECEMBER ISSUE PUBLISHED

    DECEMBER Issue has been successfully launched on 1 December 2021.

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI )